Endofund S.A.
Other financial service activities, except insurance and pension funding not elsewhere
Overview
Endofund is a company that specializes in medical factoring, providing short-term investment opportunities with guaranteed returns. Investors can earn monthly interest and receive their full capital back after four months by financing contracts with medical companies. The investments are secured through contracts and promissory notes, ensuring that funds are allocated to verified medical firms for equipment supply to hospitals.
Financials
Revenue history (in k)
From the notes
| Profit allocation | Retained in reserve capital | |
| Loans and borrowings | 1 items | |
| Capital expenditure | $47,715 | |
| Contingent liabilities | Yes | |
| Shares in other companies |
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 91 days late). 1 of 5 audited by a statutory auditor.
- 202514/07/2026
- 202414/07/2025
- 202314/07/2024
- 202214/07/2023
- 202114/10/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the company is represented independently by the sole member of the management board. If the management board is a multi-member management board, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-04-01.
20 1020 3408 0000 4102 0489 7114
76 1020 3408 0000 4702 0554 2123
26 1020 3408 0000 4802 0472 6040
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 19, 2023 | Commercial Companies Code notice | |
| Jan 12, 2023 | Commercial Companies Code notice | |
| Jan 12, 2023 | Commercial Companies Code notice | |
| Nov 21, 2022 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| SGB Faktoring S.A. | $2,947,661.61 | faktorzy.com.pl | ||
| Finea S.A. | $2,820,454.71 | finea.pl | ||
| Teylor Polska sp. z o.o. | $2,057,912.16 | teylor.pl | ||
| Pragma Adwokaci Bukowska Celary sp. k. | $512,992.96 | pragmago.pl | ||
| Flexidea Polska sp. z o.o. | $392,517.32 | flexonline.pl | ||
| Wielkopolski Fundusz Faktoringowy sp. z o.o. | $365,077.67 | wff.com.pl | ||
| Farmaceo sp. z o.o. | $352,278.08 | farmaceo.pl | ||
| WEC Financial sp. z o.o. | $286,999.14 | wecfinancial.pl | ||
| Felpol S.A. | $221,413.20 | felpol.pl | ||
| M.Capital sp. z o.o. | $188,443.62 | mcapital.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-31 | Address change (Ul. Czwartaków 14, 94-240, Łódź → Ul. Piotrkowska 46/8u, 90-265, Łódź) | |
| 2021-05-12 | Share capital increase (100,000.00 PLN → 100,960.00 PLN) | |
| 2020-07-31 | Entered in the register |
FAQ
Last updated: 2026-07-17